1.
Cook, DJ, Griffith, LE, Walter, SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5(6):368-375. doi:
10.1186/cc1071. Google Scholar |
Crossref |
Medline |
ISI2.
Maynard, N, Bihari, D, Beale, R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA. 1993;270:1203-1210. doi:
10.1001/jama.1993.03510100053032. Google Scholar |
Crossref |
Medline |
ISI3.
Skillman, JJ, Bushnell, LS, Goldman, H, Silen, W. Respiratory failure, hypotension, sepsis, and jaundice. A clinical syndrome associated with lethal hemorrhage from acute stress ulceration of the stomach. Am J Surg. 1969;117(4):523-530. doi:
10.1016/0002-9610(69)90011-7. Google Scholar |
Crossref |
Medline4.
Krag, M, Perner, A, Møller, MH. Stress ulcer prophylaxis in the intensive care unit. Curr Opin Crit Care. 2016;22:186-190. doi:
10.1097/MCC.0000000000000290. Google Scholar |
Crossref |
Medline5.
Wang, Y, Ge, L, Ye, Z, et al. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials. Intensive Care Med. 2020;46(11):1987-2000. doi:
10.1007/s00134-020-06209-w. Google Scholar |
Crossref |
Medline6.
Madsen, KR, Lorentzen, K, Clausen, N, et al. Guideline for stress ulcer prophylaxis in the intensive care unit. Dan Med J. 2014;61(3):C4811.
Google Scholar |
Medline7.
Dellinger, RP, Levy, MM, Rhodes, A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637. doi:
10.1097/CCM.0b013e31827e83af. Google Scholar |
Crossref |
Medline |
ISI8.
Rhodes, A, Evans, LE, Alhazzani, W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304-377. doi:
10.1007/s00134-017-4683-6. Google Scholar |
Crossref |
Medline |
ISI9.
Ye, Z, Reintam Blaser, A, Lytvyn, L, et al. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. BMJ. 2020;368:l6722. doi:
10.1136/bmj.l6722. Google Scholar |
Crossref |
Medline10.
Krag, M, Perner, A, Wetterslev, J, et al. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiol Scand. 2015;59(5):576-585. doi:
10.1111/aas.12508. Google Scholar |
Crossref |
Medline11.
Arabi, YM, Perner, A. Focus on fluid therapy and nutritional support. Intensive Care Med. 2018;44(12):2271-2273. doi:
10.1007/s00134-018-5429-9. Google Scholar |
Crossref |
Medline12.
Krag, M, Perner, A, Wetterslev, J, et al. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med. 2015;41(5):833-845. doi:
10.1007/s00134-015-3725-1. Google Scholar |
Crossref |
Medline13.
Litton, E, Eastwood, GM, Bellomo, R, et al. A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data. Crit Care Resusc. 2014;16(3):158-163.
Google Scholar |
Medline14.
Al-Dorzi, HM, Arabi, YM. Prevention of gastrointestinal bleeding in critically ill patients. Curr Opin Crit Care. 2021;27:177-182. doi:
10.1097/mcc.0000000000000803. Google Scholar |
Crossref |
Medline15.
Young, PJ, Bagshaw, SM, Forbes, AB, et al. Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: the PEPTIC randomized clinical trial. JAMA. 2020;323:616-626. doi:
10.1001/jama.2019.22190. Google Scholar |
Crossref |
Medline16.
Toews, I, George, AT, Peter, JV, et al. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Cochrane Database Syst Rev. 2018;6:CD008687. doi:
10.1002/14651858.CD008687.pub2. Google Scholar |
Crossref |
Medline17.
Deliwala, SS, Hamid, K, Goyal, H, et al. Proton pump inhibitors versus histamine-2-receptor antagonists for stress ulcer prophylaxis in critically ill patients: a meta-analysis and trial sequential analysis [published online ahead of print May 28, 2021]. J Clin Gastroenterol. doi:
10.1097/MCG.0000000000001562. Google Scholar |
Crossref18.
MacLaren, R, Reynolds, PM, Allen, RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med. 2014;174:564-574. doi:
10.1001/jamainternmed.2013.14673. Google Scholar |
Crossref |
Medline |
ISI19.
Lilly, CM, Aljawadi, M, Badawi, O, et al. Comparative effectiveness of proton pump inhibitors vs histamine type 2 receptor blockers for preventing clinically important gastrointestinal bleeding during intensive care: a population-based study. Chest. 2018;154(3):557-566. doi:
10.1016/j.chest.2018.05.015. Google Scholar |
Crossref |
Medline20.
Page, MJ, McKenzie, JE, Bossuyt, PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:
10.1136/bmj.n71. Google Scholar |
Crossref |
Medline21.
Stroup, DF, Berlin, JA, Morton, SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012. doi:
10.1001/jama.283.15.2008. Google Scholar |
Crossref |
Medline |
ISI22.
Wells, G, Shea, B, O’Connell, D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
Google Scholar23.
Guyatt, GH, Oxman, AD, Vist, GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-926. doi:
10.1136/bmj.39489.470347.AD. Google Scholar |
Crossref |
Medline24.
Cook, D, Guyatt, G. Prophylaxis against upper gastrointestinal bleeding in hospitalized patients. N Engl J Med. 2018;378:2506-2516. doi:
10.1056/NEJMra1605507. Google Scholar |
Crossref |
Medline25.
Cummings, P . The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163(5):438-445. doi:
10.1001/archpediatrics.2009.31. Google Scholar |
Crossref |
Medline26.
Cook, D, Guyatt, G, Marshall, J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med. 1998;338:791-797. doi:
10.1056/NEJM199803193381203. Google Scholar |
Crossref |
Medline |
ISI27.
Lee, TC, Goodwin Wilson, M, Lawandi, A, McDonald, EG. Proton pump inhibitors versus histamine-2 receptor antagonists likely increase mortality in critical care: an updated meta-analysis. Am J Med. 2021;134(3):e184-e188. doi:
10.1016/j.amjmed.2020.08.004. Google Scholar |
Crossref |
Medline28.
Barletta, JF . Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock. Ann Pharmacother. 2014;48(10):1276-1281. doi:
10.1177/1060028014540513. Google Scholar |
SAGE Journals |
ISI29.
Bruno, JJ, Canada, TW, Wakefield, CD, Nates, JL. Stress-related mucosal bleeding in critically ill oncology patients. J Oncol Pharm Pract. 2009;15:9-16. doi:
10.1177/1078155208094122. Google Scholar |
SAGE Journals30.
Buendgens, L, Bruensing, J, Matthes, M, et al. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea. J Crit Care. 2014;29(4):696.e11-5. doi:
10.1016/j.jcrc.2014.03.002. Google Scholar |
Crossref |
Medline31.
Hsieh, HC, Lin, TH, Lee, MC, et al. Proton pump inhibitors vs histamine-2 receptor antagonists and risk of mortality in critically ill patients: a pilot analysis of multi-institutional study. Pharmacoepidemiol Drug Saf. 2019;28:577-578.
Google Scholar32.
Kondo, Y, Ohbe, H, Matsui, H, Fushimi, K, Tanaka, H, Yasunaga, H. Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis. BMJ Open. 2020;10:e037534. doi:
10.1136/bmjopen-2020-037534. Google Scholar |
Crossref |
Medline33.
Ojiako, K, Shingala, H, Schorr, C, Gerber, DR. Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation. Am J Crit Care. 2008;17(2):142-147. doi:
10.4037/ajcc2008.17.2.142. Google Scholar |
Crossref |
Medline34.
Sadaka, F, Trottier, S, Smith, T, et al. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis. Crit Care Med. 2013;41:A224. doi:
10.1097/01.ccm.0000440132.04901.39. Google Scholar |
Crossref |
Medline35.
Suzuki, J, Sasabuchi, Y, Hatakeyama, S, et al. Histamine-2 receptor antagonists versus proton pump inhibitors for septic shock after lower gastrointestinal tract perforation: a retrospective cohort study using a national inpatient database. J Intensive Care. 2020;8:56. doi:
10.1186/s40560-020-00473-0. Google Scholar |
Crossref |
Medline36.
Song, MJ, Kim, S, Boo, D, et al. Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit. Sci Rep. 2021;11:18467. doi:
10.1038/s41598-021-98069-7. Google Scholar |
Crossref |
Medline37.
Boyd, C, Hassig, T, MacLaren, R. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU. Pharmacotherapy. 2021;41:820-827. doi:
10.1002/phar.2621. Google Scholar |
Crossref |
Medline38.
Huang, M, Han, M, Han, W, Kuang, L. Proton pump inhibitors versus histamine-2 receptor blockers for stress ulcer prophylaxis in patients with sepsis: a retrospective cohort study. J Int Med Res. 2021;49(6):3000605211025130. doi:
10.1177/03000605211025130. Google Scholar |
SAGE Journals39.
Wang, Y, Ye, Z, Ge, L, et al. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis. BMJ. 2020;368:l6744. doi:
10.1136/bmj.l6744. Google Scholar |
Crossref |
Medline40.
Alhazzani, W, Alshamsi, F, Belley-Cote, E, et al. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med. 2018;44:1-11. doi:
10.1007/s00134-017-5005-8. Google Scholar |
Crossref |
Medline41.
Brophy, GM, Brackbill, ML, Bidwell, KL, Brophy, DF. Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients. Neurocrit Care. 2010;13(2):176-181. doi:
10.1007/s12028-010-9397-3 Google Scholar |
Crossref |
Medline42.
Conrad, SA, Gabrielli, A, Margolis, B, et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005;33(4):760-765. doi:
10.1097/01.ccm.0000157751.92249.32. Google Scholar |
Crossref |
Medline43.
Levy, MJ, Seelig, CB, Robinson, NJ, Ranney, JE. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci. 1997;42(6):1255-1259. doi:
10.1023/a:1018810325370. Google Scholar |
Crossref |
Medline
留言 (0)